It Is Time to Reconsider the 3% Discount Rate

Health technology assessment (HTA) guidance often recommends a 3% real annual discount rate, the appropriateness of which has received limited attention. This article seeks to identify an appropriate rate for high-income countries because it can influence projected cost-effectiveness and hence resou...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Value in health 2024-05, Vol.27 (5), p.578-584
1. Verfasser:	Cohen, Joshua T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Cost-Benefit Analysis Developed Countries - economics discount rate HTA guidance Humans present value Resource Allocation - economics Technology Assessment, Biomedical - economics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!